IQE to present at the 39th Cowen Annual Technol...
Cardiff, 25 May 2011: IQE, the leading supplier of epitaxial wafer growth
services for the wireless, optoelectronic, Solar and solid-state lighting
industries today announced that it will be presenting at the 39th Cowen Annual
Technology, Media & Telecom Conference to be held at the New York Palace Hotel,
New York, NY, on June 1, 2011.
Chief Executive Officer and Group President, Dr Drew Nelson, will be presenting
at 10:15am (ET) on Wednesday, June 1, 2011, at the New York Palace Hotel, 455
Madison Avenue, New York, NY, 10022. Dr Nelson will present an overview of IQE's
technologies, products and markets.
CONTACTS:
IQE plc (+44 29 2083 9400)
Chris Meadows
Cowen Group (+1 617 946 3869)
Brian Perry
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: IQE plc via Thomson Reuters ONE
[HUG#1518508]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.